Jeffrey Siegel, MD
Disclaimer: The views presented in this editorial do not necessarily reflect those of the U.S. Food and Drug Administration.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Jeffrey Siegel, MD, FDA/CDER/OND/ODE2/DAARP, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 22, Room 3154, Silver Spring, MD 20910; e-mail, firstname.lastname@example.org.
Siegel J. Comparative Effectiveness of Treatments for Rheumatoid Arthritis. Ann Intern Med. 2008;148:162–163. doi: https://doi.org/10.7326/0003-4819-148-2-200801150-00012
Download citation file:
Published: Ann Intern Med. 2008;148(2):162-163.
Healthcare Delivery and Policy, Rheumatoid Arthritis, Rheumatology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use